Level 2

Company Announcements

Notice of Results

Related Companies

By LSE RNS

RNS Number : 3465O
NMC Health Plc
18 August 2017
 

 

 

 

 

NMC Health plc to Report Interim 2017 Results on 23 August 2017

 

 

London, 18 August 2017: NMC Health plc (the "Company") will report its interim 2017 financial results (for the six months to 30 June 2017) on Wednesday, 23 August 2017.

 

The results are expected to be published on the Regulatory News Service at 7am UK time on that day, and shortly thereafter on the Company's website at http://www.nmchealth.com/investor-relations/.

 

Contacts

 

NMC

 

Prasanth Manghat, Deputy Chief Executive Officer

+971 (0)50 522 5648

Suresh Krishnamoorthy, Chief Financial Officer

Asjad Yahya, Investor Relations

 

+971 (0)50 591 5365

+971 (0)56 219 0975

Media


FTI Consulting, London

 

Brett Pollard / Mo Noonan

+44 (0)20 3727 1100


 

FTI Consulting, Gulf

 

Shane Dolan

+971 (0)4 437 2100

 

About NMC Health

The NMC group (the "Group") is the leading private sector healthcare operator in the United Arab Emirates, with a nation-wide network of hospitals and operations in the country since 1975. The Group currently operates or manages eight hospitals, two day-care patient centres, nine medical centres and fifteen pharmacies. In addition, the Group owns and operates Clinica Eugin in Barcelona, Spain - one of the leading fertility treatment centres globally. NMC also owns a 51 per cent. shareholding in Fakih IVF Group, the Middle East market leader for in-vitro fertilisation ("IVF") services. Moreover, NMC also owns and operates Americare Group, the leading home care provider in the UAE as well as ProVita, the pioneering provider of long-term medical care, also in the UAE. The enlarged company received almost 4.3 million patients in 2016. The Group is also a leading UAE supplier of products and consumables across several key market segments, with the major contribution coming from healthcare related products. The Group reported revenues of US$1,220.8 million for the year ended 31 December 2016.

 

In April 2012 NMC was listed on the Premium Segment of the London Stock Exchange. NMC is a constituent of the FTSE 250 Index.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NORUBVBRBRAWAAR

Top of Page